home / stock / cwbr / cwbr news

CWBR News and Press, CohBar Inc. From 05/30/23

Stock Information
Company Name: CohBar Inc.
Stock Symbol: CWBR
Market: OTC
Website: cohbar.com
Menu
CWBR CWBR Quote CWBR Short CWBR News CWBR Articles CWBR Message Board
Get CWBR Alerts

News, Short Squeeze, Breakout and More Instantly...
CWBR - Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

TAMPA, Fla. and MENLO PARK, Calif., May 30, 2023 (GLOBE NEWSWIRE) -- Morphogenesis, Inc. (“Morphogenesis”), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to c...
CWBR - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RXDX, RUTH, APGN, CWBR

NEW YORK, NY / ACCESSWIRE / May 25, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Prometheus Biosciences, Inc. (NASDAQ:RXDX...

CWBR - WKEY, BHG and EEIQ among mid-day movers

2023-05-24 12:53:19 ET Gainers: Minority Equality Opportunities Acquisition ( MEOA ) +176% . Enveric Biosciences ( ENVB ) +82% . QuantaSing Group ( QSG ) +61% . EpicQuest Education Group ( EEIQ ) +51% . GigaCloud Technology ( GCT ) ...

CWBR - Enveric, Zura top healthcare gainers; PTC Therapeutics, CohBar lead losers pack

2023-05-24 10:07:34 ET Gainers: Enveric Biosciences ( ENVB ) +100% . Zura Bio ( ZURA ) +37% . Kamada ( KMDA ) +19% . Organogenesis ( ORGO ) +16% . OptimizeRx ( OPRX ) +14% . Losers: PTC Therapeutics ( PTCT ) -24% ....
CWBR - BIOC, CWBR and QBTS among pre-market losers

2023-05-24 08:38:01 ET CohBar ( CWBR ) -22% . HeartCore Enterprises ( HTCR ) -21% . Navitas Semiconductor Corporation NVTS -20% commences $80M public offering . PTC Therapeutics PTCT -19% abandons preclinical gene therapy programs, cuts staff; C...

CWBR - CohBar Inc. (NASDAQ: CWBR) Leading the Way in Tuesday Trading Based on Percentage Gain

CohBar, Inc. (NASDAQ: CWBR) is one of today's top gainers. The company's shares are currently up 120.65% on the day to $3.42. CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and...

CWBR - CohBar, Ocean Biomedical top healthcare gainers; NantHealth, Microbot among losers

2023-05-23 10:08:04 ET Gainers: CohBar ( CWBR ) +157% . Ocean Biomedical ( OCEA ) +79% . Shuttle Pharmaceuticals ( SHPH ) +46% . Icosavax ( ICVX ) +31% . Recursion Pharmaceuticals ( RXRX ) +20% . Losers: NantHealth ( ...
CWBR - CohBar surges ~130% on proposed merger with cancer vaccine developer Morphogenesis

2023-05-23 08:50:23 ET CohBar ( NASDAQ: CWBR ) is merging with privately held personalized cancer vaccine developer Morphogenesis and the combined company is expected to operate under the name TuHURA Biosciences Inc. Under the agreement, each holder of CohBar common stock will b...

CWBR - CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer vaccine platform and preclinical tumor microenvironment modulators Lead asset, IFx-Hu2.0 , expected to enter Phase 2/3 registration trial as first-line treatment for Mer...

CWBR - CohBar, Inc. (CWBR) Q3 2022 Earnings Call Transcript

CohBar, Inc. (CWBR) Q3 2022 Results Conference Call November 8, 2022 10:00 AM ET Company Participants Jordyn Tarazi - Director of IR Joseph Sarret - CEO Kent Grindstaff - SVP, Research Jeffrey Biunno - CFO Conference Call Participants Kemp Dollive...
Previous 10 Next 10